Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $33.2 million.

  • WORK Medical Technology's Liabilities and Shareholders Equity fell 853.59% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.1 million, marking a year-over-year change of. This contributed to the annual value of $33.2 million for FY2025, which is 853.59% down from last year.
  • As of Q3 2025, WORK Medical Technology's Liabilities and Shareholders Equity stood at $33.2 million, which was down 853.59% from $34.7 million recorded in Q1 2025.
  • WORK Medical Technology's 5-year Liabilities and Shareholders Equity high stood at $36.3 million for Q3 2024, and its period low was $30.0 million during Q3 2023.
  • Its 3-year average for Liabilities and Shareholders Equity is $33.5 million, with a median of $33.9 million in 2025.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 2100.1% in 2024, then tumbled by 853.59% in 2025.
  • WORK Medical Technology's Liabilities and Shareholders Equity (Quarter) stood at $30.0 million in 2023, then rose by 21.0% to $36.3 million in 2024, then decreased by 8.54% to $33.2 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $33.2 million for Q3 2025, versus $34.7 million for Q1 2025 and $36.3 million for Q3 2024.